2023
IgA Vasculitis Nephritis (Henoch-Schönlein Purpura Nephritis)
Shin J. IgA Vasculitis Nephritis (Henoch-Schönlein Purpura Nephritis). 2023, 765-782. DOI: 10.1007/978-3-031-11665-0_27.Peer-Reviewed Original ResearchHenoch-Schonlein purpuraIgA vasculitisRenal involvementDecreased factor XIII activityPathogenesis of IgA vasculitisAssociated with renal involvementDegree of renal involvementMethylprednisolone pulse therapyDevelopment of nephritisSevere abdominal symptomsLong-term prognosisOccurrence of relapseFactor XIII activityIgA vasculitis nephritisMesangial proliferative glomerulonephritisDegree of mesangial hypercellularityRandomized Controlled TrialsPulse therapyCorticosteroid therapyMycophenolate mofetilImmunosuppressive interventionsSystemic vasculitisAbdominal symptomsAbnormal coagulationVasculitis nephritis
2016
Henoch-Schönlein Purpura Nephritis
Shin J. Henoch-Schönlein Purpura Nephritis. 2016, 781-798. DOI: 10.1007/978-3-662-52972-0_29.Peer-Reviewed Original ResearchHenoch-Schonlein purpuraSevere HSP nephritisHSP nephritisRenal involvementDecreased factor XIII activityPathogenesis of Henoch-Schonlein purpuraAssociated with renal involvementDegree of renal involvementMethylprednisolone pulse therapyDevelopment of nephritisSevere abdominal symptomsHenoch-Schonlein purpura nephritisLong-term prognosisOccurrence of relapseFactor XIII activityMesangial proliferative glomerulonephritisDegree of mesangial hypercellularityRandomized Controlled TrialsPulse therapyCorticosteroid therapyImmunosuppressive interventionsSystemic vasculitisAbdominal symptomsAbnormal coagulationProliferative glomerulonephritis
2010
Intravenous dexamethasone followed by oral prednisolone versus oral prednisolone in the treatment of childhood Henoch–Schönlein purpura
Shin J, Lee S, Lee J, Kim K. Intravenous dexamethasone followed by oral prednisolone versus oral prednisolone in the treatment of childhood Henoch–Schönlein purpura. Rheumatology International 2010, 31: 1429-1432. PMID: 20464400, DOI: 10.1007/s00296-010-1507-1.Peer-Reviewed Original ResearchConceptsHenoch-Schonlein purpuraOral prednisoloneAbdominal painIntravenous dexamethasonePL groupDiagnosis of Henoch-Schonlein purpuraResolution of abdominal painHSP childrenIntravenous corticosteroid therapySevere abdominal painDevelopment of nephritisFrequent abdominal painDuration of fastingEffective therapeutic strategyPersistent nephritisCorticosteroid therapyPalpable purpuraFollow-upPrednisolonePainTherapeutic strategiesPatientsPurpuraDexamethasoneSevere symptoms
2008
Comparison of Clinical Outcome According to the Duration of Corticosteroid Therapy in Childhood Henoch-Schönlein Purpura: a Bicentric Study
Lee S, Shin J, Lee C, Kim K. Comparison of Clinical Outcome According to the Duration of Corticosteroid Therapy in Childhood Henoch-Schönlein Purpura: a Bicentric Study. Childhood Kidney Diseases 2008, 12: 170-177. DOI: 10.3339/jkspn.2008.12.2.170.Peer-Reviewed Original ResearchDuration of corticosteroid therapyCorticosteroid therapyGroup ACumulative dose of prednisoloneDuration of steroid therapyDuration of steroid useIncidence of abdominal painHenoch Schonlein purpura(HSPIncidence of relapseComparison of clinical outcomesDose of prednisoloneWhite blood cell countDevelopment of nephritisHenoch-Schonlein purpuraBlood cell countDiagnosis of HSPSteroid therapyAbdominal painRenal involvementBicentric studyPlatelet countSteroid useCumulative doseAlbumin levelsClinical outcomes
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply